Speaker illustration

Professor Nebojsa Radovanovic

Emergency Center, Clinical Center of Serbia, University of Belgrade, Belgrade (Serbia)

Member of:

European Society of Cardiology

Adding clinical markers of more severe form of intermediate-high risk pulmonary embolism improves risk stratification and possibly identifies candidates for fibrinolytic therapy

Event: ESC Acute CardioVascular Care 2022

Topic: Clinical

Session: Cardiac arrest, rhythm and other


Propensity score adjusted analysis of the association of thrombolytic therapy and 30-days outcome in patients with intermediate risk pulmonary embolism

Event: Acute Cardiovascular Care 2016

Topic: Thrombosis / embolism

Session: DVT and pulmonary embolism


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb